Australia has introduced Moderna’s bivalent vaccine into the COVID-19 booster program, which is anticipated to provide more protection against the Omicron variants. The Australian Technical Advisory Group on Immunisation (ATAGI) recommended that the Moderna bivalent vaccine, that targets both the original Wuhan strain and the Omicron variant BA. 1, be used as a booster dose…

Canada on Friday authorised updated COVID-19 booster shots from Pfizer Inc and its partner BioNTech SE that target the Omicron BA.4 and BA.5 subvariants, according to the government’s website. Pfizer and BioNTech said in a joint statement the companies will make “significant volumes of the vaccine available in the coming days”. The booster shot, which…

A healthy 35-year-old woman who experienced a seizure two days after her second dose of Moderna’s COVID-19 vaccine was diagnosed with limbic encephalitis, a rare form of brain inflammation, which the authors of a case report said was caused by the vaccine. This article was originally published by The Defender – Children’s Health Defense’s News…

Moderna yesterday filed patent infringement lawsuits against Pfizer and BioNTech, alleging the two companies copied Moderna’s patented mRNA technology. However, in an interview with The Defender, Dr. Robert Malone said the patents are derived from his own work on mRNA technology and they are now expired. This article was originally published by The Defender –…

The U.S. Food and Drug Administration (FDA) today, June 28, will vote on the “Future Framework,” a scheme that would allow Pfizer and Moderna to “reformulate” COVID-19 mRNA vaccines in perpetuity, without conducting clinical trials on the new vaccines.  The “Future Framework” is coming from the World Health Organization, and the Bill & Melinda Gates…

Switzerland has approved Moderna’s COVID-19 vaccine for children aged 6 to 11 years, according to Swissmedic, the country’s surveillance authority for medicines and medical devices. Moderna’s Spikevax COVID-19 vaccine will be administered to the children in two half-doses of 50 micrograms each at an interval of four weeks, Swissmedic said in a news release dated May…

The U.S. Food and Drug Administration (FDA) has announced tentative June dates for the meeting of its advisory committee to discuss authorizing COVID-19 vaccines for young children below the age of five years. FDA has set aside June 8, 21, and 22 for virtual meetings of its Vaccines and Related Biological Products Advisory Committee. The…

The Australian government has finalised a 10-year partnership agreement with Moderna and the state government of Victoria to manufacture mRNA COVID-19 vaccines and other mRNA vaccines in the state. “This is an Australian made shot in the arm that will protect Australians from future pandemics and secure a new manufacturing capability right here on our…

The Moderna COVID-19 vaccine has now been approved as the primary course for children aged 6 to 11 in Australia. Speaking at the press conference on Feb. 23, Health Minister Greg Hunt said Moderna gives “more choice and flexibility” for parents along with the Pfizer vaccine which is approved for children aged 5 and older….

A clinical study conducted by the Royal Melbourne Hospital of a 20 year old man exhibiting symptoms of myocarditis upon the second administration of a COVID-19 mRNA vaccine concluded that given the scarcity of myocarditis, COVID-19 mRNA vaccine are still “overwhelmingly favourable for all age and sex groups, including young people.” The research team, led…